Podcasts about Civica

Ilaria Perversi"Lontano, lontanissimo"Edizioni Lapiswww.edizionilapis.itMartina è l'unica bambina della sua classe a compiere gli anni durante le vacanze estive. Ogni anno, alla fatidica domanda “Dove vuoi festeggiare il tuo compleanno?”, la risposta è sempre la stessa: “Lontano, lontanissimo!”. Così, tra montagne innevate, giungle misteriose e metropoli sfavillanti, Martina spegne le candeline in posti incredibili.Ma quest'anno qualcosa va storto. Un imprevisto la costringe a rimanere a casa, e Martina si ritrova ad affrontare una paura che non aveva mai voluto ammettere: e se, restando qui, nessuno si ricordasse del suo compleanno?Quello che scoprirà, però, è che l'affetto delle persone non ha bisogno di grandi viaggi per farsi sentire. Il vicino di casa finalmente può farle gli auguri il giorno giusto, la zia la chiama senza problemi di segnale, e la sua migliore amica è lì con lei. Alla sera, con una fetta della sua pizza preferita e un atlante tra le mani, Martina spegne le candeline senza esprimere un desiderio: non ce n'è bisogno.Un albo illustrato che parla di attese, insicurezze, della paura di essere dimenticati, del calore di chi ci vuole bene - ovunque ci troviamo - e dell'importanza di dare agli altri la possibilità di dimostrare il loro affetto. Età di lettura dai 5 anniIlaria PerversiNata e cresciuta a Milano, dopo un diploma in Digital Animation, decide di dedicarsi primariamente alla letteratura per l'infanzia in qualità di autrice e illustratrice con diverse case editrici italiane, ma Ilaria Perversi anche disegnando per giochi, magazine, video animati, app interattive. Insegna Animazione alla Civica scuola di cinema Luchino Visconti e Illustrazione per Feltrinelli Education.IL POSTO DELLE PAROLEascoltare fa pensarewww.ilpostodelleparole.itDiventa un supporter di questo podcast: https://www.spreaker.com/podcast/il-posto-delle-parole--1487855/support.

I nuovi gestori dell'istituzione comunale, Marco Semeraro e Carolina Barbero, Illustrano corsi e progetti, nello spazio condotto da Stefano Brocks su Radio Pnr

Are you a Californian who feels isolated and alone in your political views in a deep blue state? Feel like you can't talk about insane taxes, an overbearing government, and radical social experiments without getting a side eye? Then join us on the California Underground Podcast to hear from people just like you.  Original air date 1.26.25 Summary In this episode of the California Underground Podcast, hosts Phil and Camille discuss various pressing issues in California, including the recent rain and its implications, the deployment of troops to the border, the TikTok trend involving ICE agents and teachers, the role of sheriffs in immigration enforcement, Gavin Newsom's insulin initiative, and the political controversies surrounding Westminster City Councilwoman Amy Fan West. The conversation highlights the complexities of immigration policy, the impact of local governance, and the importance of accountability in politics. Chapters 02:51 Cringe Moment: ICE Agents vs. Teachers on TikTok 12:16 Military Troops at the Border: A National Security Debate 25:44 California Sheriffs and Immigration Enforcement 34:43 Gavin Newsom's Insulin Initiative: Overpromised and Underdelivered 40:02 California's Pharmaceutical Promises and Delays 43:59 Gavin Newsom's Leadership: Over-Promising and Under-Delivering 48:56 Civica's Insulin Manufacturing: Funding and Accountability 52:55 Amy Fan West: Political Controversies and Accountability 01:08:47 The Importance of Local Elections and Political Integrity *The California Underground Podcast is dedicated to discussing California politics from a place of sanity and rationality.* Check out our full site for more information about the show at ⁠www.californiaunderground.live⁠ Follow California Underground on Social Media   Instagram: ⁠www.instagram.com/californiaunderground⁠  X: ⁠https://twitter.com/CAUndergound⁠ Tik Tok: ⁠https://www.tiktok.com/@californiaunderground?_t=8o6HWHcJ1CM&_r=1⁠ YouTube: ⁠https://www.youtube.com/channel/UCj8SabIcF4AKqEVFsLmo1jA⁠  Read about our Privacy Policy: ⁠https://www.spotify.com/us/legal/privacy-policy/⁠ 

Insieme al direttore d'orchestra Angelo Borgia, parliamo di una ricorrenza novese che animerà le vie del centro, un concerto itinerante adatto a tutte le età

There's a lot of concern right now about healthcare affordability, but not enough action. Paul Markovich, the CEO of Blue Shield of California, is on a mission to bring down health costs by reducing administrative overhead and negotiating lower drug prices. In this episode we dive deep into Paul's call to action for healthcare leaders to tackle the affordability crisis head-on. Paul and I discuss:How Blue Shield slashed the cost of arthritis drug Humira, by offering a biosimilar at 25% of the costWhy reducing healthcare costs is critical to averting a national economic crisisWhether we need a new national mandate for health data sharingPaul's advice on tackling fear and being a brave leaderPaul says healthcare affordability isn't just a pocketbook issues for patients, it's also a huge economic issue for the nation:“The reality is we are facing a huge affordability crisis, a fiscal crisis right now. Even though our economy is running pretty much at or near full employment, we have record fiscal deficits… We cannot keep spending on this program the way that we are. We need to bring the spending down... Even our dysfunctional political system is going to have to deal with that.”Relevant LinksCalifornia's new data sharing law Announcement of new Humira biosimilar Investment in nonprodit Civica for lower cost genericsNew prior authorization platform with SalesforceAbout Our GuestPaul Markovich is Chief Executive Officer of Blue Shield of California, a nonprofit health plan with $25 billion in annual revenue serving 4.8 million members in the state's commercial, individual, and government markets. Markovich has launched and led numerous initiatives to drive innovation and help reimagine healthcare, including funding support for a statewide provider directory to make it easier for Californians to find physicians and facilities in their plan; supporting development of a statewide health information network for patients' records, enabling more seamless and holistic care; and investing in a partnership with the California Medical Association to help physicians pilot new care delivery models and leverage technology.Markovich is a North Dakota native and Rhodes Scholar with a master's in Philosophy, Politics and Economics from Oxford University. He is a graduate of Colorado College, where he earned a Bachelor of Arts in International Political Economy and played Division I hockey.Source: https://www.blueshieldca.com/en/home/about-blue-shield/corporate-information/leadership/paul-markovichStay InformedSign up for The Other 80 Newsletter to receive a monthly update with reflections, news, events, jobs and funding curated for you by Claudia. Click here to sign up.Connect With...

La Corte costituzionale ha depositato la sentenza sull'Autonomia differenziata, dopo che a novembre era stata annunciata la dichiarazione di parziale incostituzionalità della riforma voluta dalla Lega e scritta dal ministro Roberto Calderoli. Nella sentenza firmata dal giudice Giovanni Pitruzzella, si specificano esattamente su quali questioni il parlamento dovrà intervenire con una modifica costituzionalmente orientata. Tra i rilievi vi sono le materie intrasferibili che erano state fissate all'articolo 117 della Costituzione e che sono state violate dalla legge illegittima voluta dal governo. Sono le materie in cui, dice la Consulta, “predominano le regolamentazioni dell'Unione europea” come la politica commerciale comune, la tutela dell'ambiente, la produzione, trasporto e distribuzione nazionale dell'energia e del sistema elettrico e le grandi reti di trasporto e di navigazione, le norme generali sull'istruzione che hanno una «valenza necessariamente generale ed unitaria», le funzioni relative alla materia delle “professioni”, in particolare quelle ordinistiche, e i sistemi di comunicazione (elettronica o di internet) che hanno finalità di tutela dei consumatori e dunque afferiscono alla materia “tutela della concorrenza”. Come nel caso dei migranti in Albania un tribunale deve ricordare alla maggioranza di governo che esiste una gerarchia delle leggi che deve essere rispettata e che nulla ha a che vedere con il “mandato del popolo” o altre sciocchezze elementari simili. Di solito il concetto di norme superiori e norme inferiori si studia in educazione civica nella scuola secondaria di primo grado, alle scuole medie. Ma evidentemente al governo urge un ripasso generale. #LaSveglia per La NotiziaDiventa un supporter di questo podcast: https://www.spreaker.com/podcast/la-sveglia-di-giulio-cavalli--3269492/support.

L' Artg musical porta in concert da gala d'in dals megliers orchester d'instruments a flad da la Svizra. La Civica Filarmonica di Lugano è vegnida fundada l'onn 1830 sin iniziativa da var ventg musicists amaturs da Lugano. In'uniun ch'è oz la pli veglia da la citad da Lugano. L'istorgia musicala da la band è caracterisada d'ina stenta permanenta da daventar adina meglra, Dapi decennis tutga la Civica tar ils megliers orchesters d'instruments a flad da la Svizra. Quai cumprovan er ils set titels ch'ella ha gudagnà a festas federalas da musica.

ROMA (ITALPRESS) - “Senza Comuni coraggiosi e capaci non ci sarà transizione Ecodigital e nemmeno benessere dei cittadini. E auguro buon lavoro all'amico Gaetano Manfredi, primo sindaco di Napoli a ricoprire la presidenza dell'Anci, un uomo di cultura e un innovatore”. Lo dichiara Alfonso Pecoraro Scanio, presidente della fondazione UniVerde, promotore della rete civica Ecodigital e già ministro, che aggiunge: “Occorre che il Governo aumenti le risorse e gli strumenti a disposizione dei comuni con particolare attenzione a tutti i piccoli centri a rischio spopolamento che presidiano un territorio fragile e ancora abitato da milioni di persone. Trascurare i Comuni fa male all'Italia. Manfredi avrà l'autorevolezza necessaria per ottenere dal Governo più attenzione e l'elezione all'unanimità sarà d'aiuto”.sat/gsl

Paula Oliveto, Diputada Nacional (Coalición Civica) @pau_oliveto @rosca_casta 5-11-2024

Questa settimana si terrà la 13° edizione del #bibliopride. Anche la Biblioteca Civica Tommaso De Ocheda di Tortona invita i lettori e le lettrici a scattare una foto con il proprio libro preferito e a taggare la pagina della Biblioteca con il tag #bibliopride. Ne abbiamo parlato con la responsabile Cinzia Rescia.

Claudio Angelini"Ipercorpo Festival"XX festival internazionale delle arti dal vivoForlìwww.ipercorpo.itAnche quest'anno il programma punta ad approfondire la “ricerca linguistica nelle più svariate direzioni che riguardano l'arte dal vivo, azzardo, sperimentazione, esperienza di ascolto, assunzione di responsabilità dello sguardo”, come spiega Claudio Angelini, direttore e co-curatore della sezione teatro e danza. Il cartellone include gli spettacoli Femina di Abbondanza/Bertoni e Voodoo di Masque Teatro. Sul palco anche il collettivo MK con il progetto Piscina Mirabilis, pensato per tutti coloro che vogliono danzare liberamente, senza paura del giudizio; a esibirsi saranno anche i danzatori della Civica scuola di teatro Paolo Grassi. In programma anche la monografia video dedicata al filosofo Carlo Sini, presentata da Teatro Akropolis, e la proiezione di Timecode (2016) di Juanjo Giménez Peña, vincitore della Palma d'oro a Cannes nella categoria cortometraggi.La sezione musicale del festival, curata da Elisa Gandini e Davide Fabbri, ospita il progetto inedito Sinfonico Spontaneo, che riunisce Roberto Villa, Andrea Faccioli, Diego Sapignoli, Marco Frattini, Moder e Vanni Crociani. Ad attendere gli spettatori anche Risonanza nostalgica, una sala di ascolto appositamente allestita per tutta la durata del festival con ampia selezione di CD. Curata da Davide Ferri con la collaborazione di Miral Rivalta, la sezione arte propone invece una serie di performance site-specific al tramonto, che interagiscono con l'ambiente circostante. C'è poi il laboratorio di scrittura critica di Altre Velocità, che coinvolgerà un gruppo di ragazzi e ragazze tra i 18 e i 29 anni invitandoli a raccontare il festival.IL POSTO DELLE PAROLEascoltare fa pensarewww.ilpostodelleparole.itDiventa un supporter di questo podcast: https://www.spreaker.com/podcast/il-posto-delle-parole--1487855/support.

In this episode, we dive into the incredible journey of Zara Lachlan, a 21-year-old adventurer who's about to take on one of the most daunting challenges imaginable. This October, Zara will row solo and unsupported across 3,600 miles of the Atlantic Ocean, from Portugal to French Guiana. If successful, she'll set three world records: the first female to complete this crossing solo and unsupported, the youngest person to do so in any boat, and the youngest female to row from mainland to mainland across the Atlantic.But this isn't just about records. Zara will be rowing 15 hours a day through orca and shark-infested waters, battling waves up to 30 feet high—all on her very first ocean crossing. And the first time she'll ever row on the open ocean? The moment she leaves the shore in Portugal.This epic journey wouldn't be possible without the support of her sponsors, including Team Forces, Collins Aerospace, Telent, Civica, and Spectra Group. Zara's mission is also a fundraising effort for two causes close to her heart: Women in Sport and Team Forces.Tune in as Zara shares her top tips for pushing through limits and making dreams a reality. This is an episode you won't want to miss! Hosted on Acast. See acast.com/privacy for more information.

See omnystudio.com/listener for privacy information.

Per la serie di interviste con le liste che compongono le coalizioni per le elezioni comunali di Tortona, ospite dello Speciale condotto da Stefano Brocks sono alcuni candidati al consiglio comunale per la Lista Civica Morreale, a sostegno della candidatura a sindaco di Federico Chiodi.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Aleksej ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Stamattina l'affissione del cartellone nei pressi della scuola cittadina del Fusinato, provocando la reazione immediata dei consiglieri comunali di minoranza De Zen e Cunegato. Contestato il messaggio che richiama all'islamofobia e richiesta alla candidata sindaca Marigo, di area civica di centrodestra, di dissociarsene.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Bruna ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Anastasia ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Cristian ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Aleksej ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

ROMA (ITALPRESS) - "Cercare di azzerare il numero dei morti, che sono figli della precarietà e dell'incertezza, trovare un modo di ridistribuire la ricchezza per consentire a tutti di vivere dignitosamente”, sono i temi focali indicati da Alberto Civica, segretario generale della Uil Roma e Lazio, in un'intervista all'Italpress.ads/mrv

ROMA (ITALPRESS) - "Cercare di azzerare il numero dei morti, che sono figli della precarietà e dell'incertezza, trovare un modo di ridistribuire la ricchezza per consentire a tutti di vivere dignitosamente”, sono i temi focali indicati da Alberto Civica, segretario generale della Uil Roma e Lazio, in un'intervista all'Italpress.ads/mrv

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Bruna ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

E' la Schio dei più fragili e delle retrovie quella raccolta sotto un nuovo vessillo a sostegno della candidatura di Cristiano Eberle alla poltrona di sindaco della città laniera: "Schio per tutti" ad indicare quel carattere inclusivo che fa della civica capeggiata da Maura Fontana la quarta lista di fatto dopo Nuova Trama, Coalizione Civica e Partito Democratico a supportare il candidato del centrosinistra verso l'election day dell'8 e 9 giugno prossimi.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Cristian ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Aleksej ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

Con Carlos Mira fuera de Buenos Aires, Carlos Ponzio entrevista en Mira quién Habla edición verano a Francisco Mones Ruiz, concejal de Morón por la Coalición Civica.

Questa settimana, per la rubrica dedicata alla Biblioteca Civica Tommaso de Ocheda di Tortona, Bruna ci ricorda le iniziative in programma per la promozione della lettura. Infine, come di consueto, alcuni consigli di lettura per adulti e bambini.

IN THIS EPISODE:For the past 15 years, drug shortages have been a persistent problem for hospitals and thepatients they serve – and extreme cases can even lead to rationing, delaying, or cancelingtreatments or procedures.Tackling the drug shortage crisis is a complicated issue requiring creative solutions. That's whereCivica comes in – a non-profit pharmaceutical company created by hospitals and health systemsto address these critical shortages.In this episode, Chip speaks with Civica's Senior Vice President for Public Policy Allan Coukellabout why the company was formed, the challenges they are tackling, and how it plans to helppatients into the future. Topics include:The state of hospital drug shortages in the US todayTaking the bull by the horns: how a non-profit company created by hospitals is helpingpatients.The success of Civica's model:Long-term purchase and supply contracts directly with hospitals that add stabilityto the market.Maintaining an approximately 6-month buffer inventory of every drug.US sourcing whenever possible.Intensive quality oversight of suppliers.A single cost-plus price, available to every purchaser.How the company got into drug production.Policy solutions to ease drug shortages.GUEST:Allan Coukell, Senior Vice President. Public Policy, Civica Inc.MORE:Civica currently delivers 80+ drugs, all chosen by US hospitals for being at risk of shortage, withmore than 140 million containers delivered to hospitals over five years, serving 60 millionpatients.It currently works with 1,500+ hospitals from 55-member health systems, like HCA Healthcare,Mayo Clinic, Common Spirit & US Department of Veterans Affairs.Learn more here: https://civicarx.org/

Escuche esta y más noticias de LA PATRIA Radio de lunes a viernes por los 1540 AM de Radio Cóndor en Manizales y en www.lapatria.com, encuentre videos de las transmisiones en nuestro Facebook Live: www.facebook.com/lapatria.manizales/videos

Imagine a unique governance structure that safeguards its mission against the volatile tides of the market. In this episode, Dan Liljenquist, the board chair of Civica Rx, joins Kedar and Don to shed light on Civica's remarkable mission of making essential generic medications both accessible and affordable to patients across the nation. Dan shares how Civica Rx has already had a profound impact, with over 125 million units of essential medicines supplied to over 1500 U.S. hospitals, and is changing the game in terms of pricing, shortages, and market stability. He explains the ethics behind Civica Rx, the non-profit model ensuring the organization's governance and its steadfast commitment to transparency in pricing, aiming at a fair, sustainable market price for all. Dan also discusses the potential expansion of this model into other areas of healthcare, the challenges posed by monopolies in the drug supply, and how Civica Rx is using its leverage to address systemic issues and stabilize a market fraught with abuse and failure. Tune in to this episode for a deep dive into Civica's revolutionary model aiming to ensure drug availability and pricing stability. Learn more about your ad choices. Visit megaphone.fm/adchoices

Calling in to talk to Karen at the bottom of the 7 o'clock hour is Ned McCoy, the CEO of Civica, a generic pharmaceutical company -- which is bringing jobs and production to Virginia (both in Petersburg and Chesterfield County).  Ned discusses the shortcomings of health care in our country and describes Civica's efforts to reduce health care-related costs for consumers.

In this episode, Ned McCoy, President & Chief Executive Officer at Civica, sits down with Ankit Aggarwal to discuss generic injectable drug shortages in the United States and what Civica is doing to tackle the issue by creating a non-stock, non-profit entity in partnership with major hospitals and health systems.   Ned McCoy has been with Civica since its 2018 launch and prior to being CEO, served as Chief Operating Officer where he was responsible for commercial operations, research and development, manufacturing/supply chain and business development. Ned initially joined Civica as the Chief Business Development Officer, responsible for developing and signing long term supply partnerships to prevent drug shortages and establish fair pricing. Prior to Civica, Ned had a successful career of 32 years with Abbott across various business divisions and roles.   The Healthcare Community at Kellogg is always looking to collaborate with industry leaders. To learn more about Healthscape or the Kellogg Healthcare Club, please contact Pam Divack.

After years of anticipation, California Gov. Gavin Newsom said the state would contract with Civica, a Utah-based generic pharmaceutical company, to start producing California-branded insulin, available for $30 for a 10 mL vial. Once the Food and Drug Administration approves the new insulin, Civica can begin manufacturing. Reporter Rachel Bluth talks with host Ben Leonard about about the deal.

It's In the News, a look at the top stories and headlines from the diabetes community happening now. This week, Dexcom sets a US release date for the G7, we find out whether Tandem will be a Tidepool Loop partner now that Insulet and Medtronic are out, Omnipod Eros to be discontinued, a new study says there's a better age to test kids for type 1, a new smart insulin pen sensor can also be used to track dosing of GLP-1 medications, a new twist in the Faustman study of the TB vaccine to treat diabetes, the Sims 4 update brings CGMs to the game and more. Links and transcript below Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode Transcription:  Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by VIVI Cap – confidence on the go that keeps your insulin protected in hot or cold XX Learning a bit more about the Tidepool pump partnership, at least who it won't be. When Tidepool Loop approval was announced last month, it came without the original pump partners, Omnipod and Medtronic. CEO Howard Look said they do have a pump partner but that they're not ready to announced yet. I spoke to Tandem for next week's episode and they say its' not them. Quote “That's not part of our roadmap, it's not an integration we're working on.” XX Insulet announces it will discontinue the original Omnipod system. In a letter to healthcare professionals, the company says the system, referred to as Eros or Omnipod Classic will be discontinued at the end of this year. It's no longer available to new patients and existing customers will be transitioned to Dash or Omnipod 5. I'll link up the letter in the show notes. “Dear healthcare professionals, We have made the decision to discontinue the original omnipod insulin management system in the us after December 31 2023. This system is often referred to omnipod eros or omnipod classic. Insulet will continue to support the omnipod system throughout this year to allow existing patients ample time to transition to newer omnipod technology such as Omnipod dash or Omnipod 5. please note this product is no longer available for new patients in the US. After December 31, 2023 Insulet will not be able to guarantee the availability of the omnipod system supplies. “ https://www.facebook.com/photo/?fbid=10225188520677483&set=a.1253748061199 XX Civica continues to move ahead with more affordable insulin, announcing that Ypsomed will make and supply their pens. Civica plans to produce three insulin biosimilars priced at no more than $30 per vial and no more than $55 for a box of five pen cartridges. Contingent on FDA approval, Civica anticipates that its insulins will be available for purchase beginning as soon as 2024. XX New study shows screening kids at risk for type 1 diabetes only once – at age ten – is very effective in detecting the condition by the age of 18. These researchers also say “Almost no one” who is islet autoantibody negative at age 10 years despite a high familial risk for type 1 diabetes will develop clinical diabetes by the age of 18. Full study published in the Lancet. https://www.medwirenews.com/diabetes/age-10-years-optimal-type-1-diabetes-screening-point/23957596 https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00350-9/fulltext?fbclid=IwAR2kRNyGg6lnq3ZWsFkXnCvkeNiisg9mE2bbN_OnGiLrUpcHKXAaff3OkE4 XX The nonprofit public health advocacy group the Physicians Committee issued a formal complaint that a recent CBS "60 Minutes" segment was a promotion for Novo Nordisk's obesity drug, Wegovy, that was dressed up as a news segment. The Washington, D.C.-based group has filed a complaint with federal bodies alleging that the CBS "60 Minutes" segment that aired on New Year's Day breached the FDA's “fair balance” rules for drug ads. The Committee said in a release that the feature failed to talk about alternatives to the drug or about other weight-loss methods; that only experts “paid by Novo” were used in the program; and that the piece used overly promotional language. This has caused Wegovy supply issues for Novo which, coupled with manufacturing problems, only deepened bumps in production last year for the drug and led to an official shortage of the drug in 2022. A spokesperson for Novo Nordisk told Fierce Pharma Marketing: “Novo Nordisk did not provide any payment or sponsorship to CBS 60 Minutes for their reporting on obesity as part of a news segment that aired on January 1, 2023, and we did not control any of the content or have any role in identifying or selecting the doctors and patients featured in the news segment.” https://www.fiercepharma.com/marketing/health-group-lambasts-novo-nordisk-60-minutes-paid-news-program-weight-loss-med-wegovy XX Some researchers have pulled out of a trial investigating the use of an old tuberculosis vaccine to treat children with Type 1 diabetes only months after they began enrolling participants. This is part of the Faustman study of the BCG vaccine. Some recent research suggests that the vaccine, first administered in 1921, also may protect against Covid-19 and respiratory diseases because of its broad effects on the immune system. The lead investigators of the pediatric trial are proceeding with the study, but N.Y.U. Langone's abrupt withdrawal could potentially jeopardize its viability if they are unable to collect data on the children at the N.Y.U. site. An earlier study by the scientists at Massachusetts General found that two doses of B.C.G. vaccine reduced blood sugar levels to near normal in a very small group of adults with Type 1 diabetes. Other studies of B.C.G., using different versions of the vaccine and following Type 1 diabetes subjects for varying periods of time, have yielded mixed results. The lead investigator of the trial, Dr. Denise Faustman, director of the immunobiology laboratory at Massachusetts General Hospital, said that N.Y.U.'s withdrawal was a serious deviation from trial protocol that may call into question the final results. https://www.nytimes.com/2023/01/20/health/diabetes-bcg-nyu.html XX A new smart insulin pen sensor can also be used to track dosing of GLP-1 medications. Brand names for GLP-1 medications include Trulicity and Ozempic. This device, called Mallya, attaches to the injector and connects it to a mobile app. It's already cleared in Europe and should be available in the US in the next few months. The device is compatible with most popular insulin pens, including Lilly's Kwikpen, Sanofi's Solostar, and the Novo Nordisk FlexPen. Biocorp also announced that it has partnered with Novo Nordisk, Sanofi, and Roche Diabetes Care to improve Mallya's current design moving forward. According to the Mallya website, the device's lifespan is two years before a replacement is needed, and in no way does it change the way that users operate their insulin pen. The device can be charged via USB and, with average use of three to four injections per day, requires charging once a month. Also, for those who have different pens for multiple types of insulin, the app can connect multiple Mallya devices, one for basal insulin and another for bolus, for instance. https://diatribe.org/fda-clears-smart-injector-pen-device-mallya XX Tempramed/ VIVI Cap XX New features popped up this week in the latest version of The Sims – after an update, players can opt for their characters to wear a CGM – Libre or Dexcom Freestyle Libre in the Sims 4 game. Search for CGM or Libre XX The Jonas Brothers officially have a star on the Hollywood Walk of Fame. On Monday, Nick, Joe and Kevin Jonas were honored during a ceremony on Hollywood Boulevard where their careers as musicians were celebrated. Their star was dedicated in the category of Recording and the trio was introduced by Monte and Avery Lipman of Republic Records, Ryan Tedder and writer and producer Jon Bellion. While the brothers still maintain their own separate projects -- Nick Jonas is set to produce and star in the upcoming film "Foreign Relations," Joe Jonas recently starred in the film "Devotion," and Kevin Jonas hosts the ABC series "Claim to Fame" -- they continue to make music together and are slated to release new songs this year. The group closed out Monday's ceremony by announcing big news about their upcoming new album, which will be released in May. They also said they'll be going on tour again. XX On the podcast next week.. Tandem Diabetes with an update on their road map announced last year. They've since acquired a patch pump company and one that makes infusion sets. A lot to catch up on! This past week's long format episode is with Tidepool Loop, a deep dive into what was approved with CEO Howard Look That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

In questa pillola parliamo dello Stato e della separazione dei poteri nella storia: filosofi e politici che hanno elaborato teorie sulla separazione dei poteri - legislativo, esecutivo e giudiziario - fasi storiche e costituzioni che hanno portato all'applicazione dei principi dello Stato liberale. Se vuoi approfondire puoi farlo qui:Lo Stato e la separazione dei poteriMappa concettuale Colonna sonoraBlippy trance / Poppers and prosecco - Kevin Mac Leod

La Costituzione della Repubblica italiana è la Carta fondamentale dello Stato. In questa pillola vediamo il contesto storico entro cui è nata e cerchiamo di fare il punto sugli articoli e i principi fondamentali in cui è strutturata.Se vuoi approfondire, puoi farlo qui:- Mappa concettuale https://www.studenti.it/mappa-concettuale-costituzione-repubblica-italiana.html- Cos'è la Costituzione https://www.studenti.it/costituzione-italiana-cos-e-struttura-e-articoli-commentati.htmlColonna sonoraBlippy trance / Poppers and prosecco - Kevin Mac Leod https://incompetech.com/

Randi Haseman talks about what's new in the Clinical Leadership industry.

It's "In the News.." got a few minutes? Get caught up! Top stories this week: The Federal Trade Commission probes the prescription drug middleman industry, once a week basal insulin moves forward, DIY insuln dosing systems get a thumbs up at ADA Scientific Sessions, Sernova's stem cell system releases great findings and more! Learn more about the T1D Exchange Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX The Federal Trade Commission will launch an inquiry into the prescription drug middleman industry.. requiring the six largest pharmacy benefit managers to provide information and records. They're looking at PBMs such as CVS Caremark; Express Scripts, Inc.; OptumRx, Inc.; Humana Inc and more. The largest PBMs are now vertically integrated with the largest health insurance companies and wholly owned mail order and specialty pharmacies. In these roles, pharmacy benefit managers often have enormous influence on which drugs are prescribed to patients, which pharmacies patients can use, and how much patients ultimately pay at the pharmacy counter. https://www.ftc.gov/news-events/news/press-releases/2022/06/ftc-launches-inquiry-prescription-drug-middlemen-industry?utm_campaign=https://www.ftc.gov/news-&utm_content=1654622484&utm_medium=social&utm_source=twitter XX Confirming what many of you have known for years.. an open-source automated insulin delivery system -- also known as a do-it-yourself system -- was both safe and effective for patients with type 1 diabetes. This is from the CREATE trial, designed to test DIY system, presented for the first time at the ADA Scientific Sessions. This system was made up of the OpenAPS algorithm from a version of AndroidAPS implemented in a smartphone, paired with the DANA-i insulin pump and Dexcom G6 continuous glucose monitor. The researchers previously published additional information in the Journal of Diabetes & Metabolic Disorders. https://www.medpagetoday.com/meetingcoverage/ada/99109 XX Stem cell study showing great results. Sernova says the first three patients of six total continue to be insulin independent following treatment. One of the patients has been insulin-free for more than two years, while the other two have been free of the need for medication injections for six months and three months, respectively. At this point, the other three patients in the study have not had the device long enough to determine measurable results. The first three all have A1Cs in a normal, nondiabetic range. Sernova's Cell Pouch is an implantable device that releases the primary donor islets. The device is implanted under the skin in a minimally-invasive procedure. We're talking to Sernova for next week's show; long way to go here but another good result for stem cells. https://www.biospace.com/article/sernova-cell-pouch-device-keeps-type-1-diabetes-patient-insulin-free-for-two-years/ XX Getting closer to once-a-week basal insulin. New study says Novo Nordisk insulin icodec achieved better results than Lantus in some aspects of the study and that overall it was – this is interesting wording – non-inferior. Another previous study showed it also matched well to Tresiba, but that Tresiba caused fewer lows than the once-weekly basal. This study was about type 2 diabetes but insuln icodec is in other trials for people with type 1. https://www.biospace.com/article/novo-nordisk-scores-phase-iii-insulin-win-strengthening-market-position/ XX New partnership between Diabeloop – which makes an automated insulin algorithm - and SOOIL which makes pumps. These are two French companies that have been working together since 2020 but this new announcement was delayed by COVID. They want to bring the product – Diabeloop's DBLG-1 I controller and SOOIL's Dana ACE Pump to the US, Europe and Korea. https://www.drugdeliverybusiness.com/diabeloop-sooil-automated-insulin-diabetes/ XX Civica continues to move ahead with the development of its affordable insulins. They've announced they'll partner with the German company Profil for the clinical trials. Civica plans to set a maximum recommended price to the consumer of no more than $30 per vial and no more than $55 for a box of five pen cartridges. Contingent on FDA approval, Civica anticipates that its insulins will be available for purchase beginning in 2024. https://www.healthcarepackaging.com/supplier-news/news/22262909/civicarx-civica-selects-profil-as-clinical-trial-partner-for-affordable-insulin-initiative XX New study out of Israel shows that obesity in teenagers may lead to type 1 diabetes a few years later. The study, of nearly 1.5 million Israeli teenagers, found that those who were obese were twice as likely to develop type 1 diabetes by young adulthood, versus those in the normal weight range. The senior researcher on the study says it's not clear why obesity would raise the risk of type 1. They think it may the a trigger in people with genetically susceptible. Obesity also has other effects — including vitamin D deficiency and alterations in the gut's bacterial makeup — that could impair immune function. https://www.usnews.com/news/health-news/articles/2022-06-06/obesity-in-teen-years-might-trigger-type-1-diabetes XX Right back to the news in a moment but first we've got a new sponsor. As I mentioned, The T1D Exchange Registry is an online research study, designed to harness the power of individuals with type 1 diabetes. It's a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy Sign up at T1DExchange.org slash Stacey (that's S-T-A-C-E-Y). XX XX XX On this week's long format episode, you'll hear my conversation with Dexcom's CEO Kevin Sayer. We get more information about the G7 launch, after FDA approval of course and I asked him your questions about everything from IOS issues to airport scanners. Next week, Sernova joins me to explain their stem cell pouch technology Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

The world has changed and our approach to population healthcare must change with it Tracey Cotterill is the managing director of the population health intelligence business unit at Civica. John Doran is the head of solution strategy for the business unit that Tracy heads. Judith Boskett has been with Civica since mid-2021. She has been in healthcare sales for over twenty-five years now in Australia. Civica are a global IT-based services partner in digital solutions, software applications, and managed services. In this episode, Pete, Tracey, John and Judith have a discussion centred on population health management and costing while looking into a changed approach to improve patient outcomes that focus more on the organisation rather than the clinician and much more. This episode focuses on the benefits of data on healthcare costing and population healthcare management. It also takes a peek into value-based healthcare and why it is essential.  Check out the episode and full show notes here. To see the latest information, news, events and jobs on offer at Civica, visit their Talking HealthTech Directory here.  Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content.  For more information visit here.

Martin Van Trieste is the President and Chief Executive Officer, Civica Rx. Civica is making affordable insulin. Show notes for people who are Bold with Insulin Get your supplies from US MED with the link or 888-721-1514 Learn about the Dexcom CGM You may be eligible for a free 30 day supply of the Omnipod DASH  Get Gvoke Glucagon  Learn about Touched By Type 1 CONTOUR NEXT ONE smart meter and CONTOUR DIABETES app Tak the T1DExchange survey A full list of our sponsors  How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadioRadio Public, Amazon Music and all Android devices The show is now available as an Alexa skill. My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.

Could this finally be a big shake up in the price of insulin? Civica Rx plans to sell the most popular types of fast and long acting insulin for a flat price of 30-dollars a vial. This week you'll hear from Ned McCoy, Civica's Chief Operating Officer. He explains why they're confident this will work, who will be able to buy the finished product, when it will be available and what Civica RX is all about. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about AFREZZA* *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM*

In this episode, I am joined by my friend and fellow graduate of The Institute for the Psychology of Eating, Amy Civica. Amy is the founder of The Food Is Love Experience where Amy will help you discover your relationship with food, so you can fall in love with foods that heal you inside and out. You can follow her on Instagram at @amycivica

There's a new plan to manufacture and sell insulin at a much lower list price. The company behind it is non-profit Civica RX, which has support from JDRF. Stacey talks to JDRF CEO Aaron Kowalski about what their role is here, how realistic this plan is, who it may help and a lot more. They also spend some time talking about the reorganization of JDRF and what the future after COVID 19 looks like for them. More about Civica's Plan (we'll talk to them in a future episode) Here's the episode Stacey references with Thom Scher and Aaron Kowalski This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM*

In this episode, we are joined by Amy Civiva, Founder, and CEO of The Food is Love Experience. Amy will be sharing how important food is in the business world, what struggles she is seeing with other CEOs, and how to balance their lives more through proper eating. Balancing time, food, and some true nuggets of gold that will help you fine-tune your business through food!You will also discover how to overcome a business struggle that may help save your business. Tune in to learn more!For more go to: www.strategicadvisorboard.comConnect: Strategic Advisor Board:  www.linkedin.com/company/strategic-advisor-boardJason Miller: www.linkedin.com/in/jasontmiller-sab/

It's “In the News…” Got a few minutes? Get caught up! Top stories this week: Dexcom G7 approved in Europe, JDRF speaks out on non-profit insulin plan, Ukraine diabetes aid progress, texting for T2D, Reaction to Pixar's Turning Red -- Join us LIVE every Wednesday at 4:30pm ET Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast. XX The news is brought to you by The World's Worst Diabetes Mom: Real Life Stories of Parenting a Child With Type 1 Diabetes. Winner of best new non-fiction at the American Book Fest and named a Book Authority best parenting book. Available in paperback, eBook or audio book at amazon. XX Our top story this week.. Dexcom gets the CE Mark for it's new G7 system, which means it's approved in Europe. The approval is for people ages 2 and up, including pregnant women. I'm putting the full screen photo up here and I'll post this on the website and in the FB group for those listening.. interesting to finally get a good look at the much smaller applicator – as expected looks a lot like the Libre. Also interesting, all the PR for this has said, developed in partnership with Verily.. remember them? That was part of google, probably best known for saying they were going to develop a contact lens that would monitor glucose. I've reached out to Verily, love to know more about this partnership. Anyway, we've done a ton on G7, I'll link up some of our recent conversations with the folks at Dexcom. They submitted to the US FDA at the end of 2021, no firm timeline on US approval. https://www.medicaldevice-network.com/news/dexcom-ce-mark-g7-cgm-system/ XX Some good news about living longer with chronic conditions, including diabetes. This was a 20-year British study that ended in 2011, so one caveat here, it doesn't include COVID. Men gained 4-point-6 years of life expectancy; women gained 2-point-1. When it comes to disability-free life expectancy, men gained about a year less and women stayed the same. This included people with chronic conditions including those with diabetes. These researchers do point out that while they'd expect to see the same increase in the US – the lack of health and social safety net programs could make a negative difference here. But they point to CGM technology and better medication as making a big difference for those with diabetes. https://www.healthline.com/health-news/why-people-with-chronic-conditions-such-as-diabetes-are-living-longer-without-disability#Cognitive-impairment-is-the-exception XX Children who develop type 1 diabetes show epi-genetic changes in the cells of their immune system long before the antibodies of the disease are detected in their blood. An epigenetic change affects how our genes work. Outside factors such as environmental, viral infections, are usually the cause. These researchers say these are previously unknown changes that signal the increased risk of developing type 1 and could give an even earlier indication than the anti-body marker tests available now. https://www.news-medical.net/news/20220316/Epigenetic-changes-could-be-a-biomarker-for-early-detection-of-type-1-diabetes.aspx XX Could text-messaging with their doctors help people with type 2? A new team in Chicago is looking at text-based intervention in underserved communities. The intervention will deliver personalized information directly to patients through text messages, including reminders about self-monitoring and prescription refills, interactive office hours and general information about diabetes, motivational support and answers to frequently asked questions. These doctors say the idea is to create more opportunities for patients to meaningfully engage and reduce barriers by employing technology already in people's hands. https://today.uic.edu/an-sms-solution-for-type-2-diabetes XX Last week we told you about the effort by Civica RX to make affordable insulin. Civica, is a nonprofit generic pharmaceutical company. JDRF directed funds to this effort and CEO Aaron Kowalski wrote an op ed that I'll link up. In it, he talks about the success Civica has had lowering the costs of other medications. We'll have Kowalski on the show soon and I've reached out to Civica as well. This would lower the price to $35 a vial no matter your insurance. Congress still hung on a $35 co-pay cap for those with insurance. https://www.healthline.com/diabetesmine/op-ed-jdrf-leader-on-insulin-affordability-for-all-americans XX Over in the UK they keep moving forward – covering all 400-thousand Britons with type 1 for the Libre CGM. Former guest of the podcast, Dr. Partha Kar, says everyone with type 1 will be able to get a CGM if they want one by the end of March. It will no longer be restricted by who doctors think need it the most. By the way, Briton means someone from England, Scotland or Wales. It's the first time I'm using that word so UK friends.. let me know if I've got it right! https://www.dailymail.co.uk/health/article-10606335/All-400-000-type-1-diabetic-Britons-offered-high-tech-implant.html XX Still a big need for diabetes help to Ukraine. A lot of the efforts are paying off – Insulin for Life showing that the supplies are on their way or have arrived. Spare a Rose reports that individual donations so far have totaled more than 115-thousand-dollars. I'll keep linking up places to donate https://www.jdrf.org/blog/2022/03/02/helping-the-diabetes-community-in-ukraine/ XX Reaction to Pixar's Turning Red. I loved this. I put out a call for photos of people seeing themselves in the movie's tiny little moments of diabetes representation. Thanks to all who sent those in – you can see them on Diabetes Connections on Facebook and Twitter. And my Stacey Simms account on Instagram. It's all just one account there. XX While Turning Red had diabetes in the background.. this week on the long format episode we're talking about a movie that wants to put type 1 front and center. And it's got the Star Trek community excited as well! Meet the Star Trek Discovery actor with type 1 who's leading this effort. Next week, we're going on a deep dive about stem cell research with the folks at Viactye. They're working on two fronts now.. encapsulation AND gene editing with the people at CRISPR. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.  

It's "In the News..." Got a few minutes? Get caught up! Top story this week: Non-profit insulin announced, Tandem issues warning on some pumps, a common blood pressure med may help T1D, a potential new treatment for retinopathy and a PGA player misdiagnosed w/T2D speaks out -- Join us LIVE every Wednesday at 4:30pm EST Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast. XX The news is brought to you by The World's Worst Diabetes Mom: Real Life Stories of Parenting a Child With Type 1 Diabetes. Winner of best new non-fiction at the American Book Fest and named a Book Authority best parenting book. Available in paperback, eBook or audio book at amazon. XX Non-profit drugmaker Civica expects to launch lower-cost versions of insulin in the United States. Civica said it would produce three copycat versions of insulin, and make them available at roughly the same price for all customers, once approved by U.S. health regulators. The company's products, which would be available as both vials and pre-filled pens, are biosimilars to Sanofi Lantus, Eli Lilly's Humalog and Novo Nordisk's Novolog. The maximum price would be no more than $30 per vial and no more than $55 for a box of five pen cartridges. Civica, which was launched by seven health groups to make essential medicines available at affordable prices, expects to file for regulatory approval in 2023 with products available in 2024. https://www.saltwire.com/atlantic-canada/news/civica-aims-to-launch-low-cost-insulin-in-us-by-2024-100701260/ XX Tandem has issued an urgent field safety notice. This in Europe ONLY and is for the t-slim X2 pumps with Basil IQ technology. According to the notice, a user could inadvertently program and confirm a basal rate with an incorrectly placed decimal point. That could mean giving too much or too little insulin. Tandem says you can continue to use the pump after confirming basal rates are correct. A software update is coming. Again, this is Europe only and this is NOT an issue for any pumps on Control IQ https://www.drugdeliverybusiness.com/tandem-diabetes-warns-on-some-tslim-x2-insulin-pumps/?fbclid=IwAR0dV04W49iQ1LavAIQMkpleif77XiVqKq7ZrhUiFTrpylem-ZHIByRN8nw XX Interesting new potential treatment for diabetic retinopathy. Retinopathy happens when the disease damages tiny blood vessels in the eye, reducing blood flow to nerve cells in the retina. Treatment can be injections or laser surgery. These scientists are looking at photo-bio-modulation – which involves irradiating the eye with far-red to near-infrared light. This increases oxygen-rich blood flow to the retinal cells. They use an LED contact lens to get the light exactly where its needed. No human tests yet.. so it's a far way off. https://newatlas.com/medical/led-contact-lens-diabetes-blindness/ XX I don't have much of an update about diabetes aid to Ukraine except that it's still very much needed. If you're so inclined, we'll link up where you can donate. One partnership I didn't mention last week is one between the Ministry of Health of Ukraine, a group called Direct Relief, and the International Diabetes Federation. They are working closely together to understand where supplies are short, secure donations within and deliver them quickly to where they're needed. Lots of links to vetted organizations in the show notes and here on our fb page. https://sparearose.org/ https://www.jdrf.org/blog/2022/03/02/helping-the-diabetes-community-in-ukraine/ XX The ordinary blood pressure medication verapamil continues to show benefits in treating type 1 diabetes. Patients taking verapamil required less insulin two years after their type 1 diagnosis and also showed evidence of other surprising benefits. These researchers caution that their study is small and needs to be confirmed by larger clinical studies. There are a few other going on right now.. but the preservation of some beta cell function is very promising. https://www.uab.edu/news/research/item/12670-an-oral-medication-shows-benefits-treating-type-1-diabetes-for-at-least-two-years-after-diagnosis XX Two pieces of good news about insurance coverage. Our friends in Ontario, Canada will finally get CGM coverage. Starting March 14th the Assistive Deices Program will cover funding for a CGM and related supplies for people with type 1 . https://www.baytoday.ca/local-news/people-with-type-1-diabetes-to-get-government-funding-for-real-time-continuous-glucose-monitors-5126997 XX And in the US military families will have pharmacy coverage for Abbott's Free Style Libre 2 under Tricare Health. This should make the Flash Glucose Monitor available with zero copay to Tricare members. It begins next month. https://www.pharmacytimes.com/view/military-members-families-and-retirees-get-simplified-access-to-abbott-s-freestyle-libre-2-system-through-tricare- XX Bringing some awareness of how common a misdiagnosis is when an adult has type 1 diabetes.. professional golfer JJ Spaun is speaking up. He was diagnosed with type 2 but after a couple of years of struggling he found the right doctor and the right diagnosis. He next plays in the Players Championship this weekend we'll see if we can spot the Libre on his arm. https://www.golfchannel.com/news/after-diabetes-misdiagnosis-jj-spaun-feeling-new-person XX Our long format episode this week is all about Pixar's Turning Red. There are two background characters in the movie with diabetes and we've got the behind the scenes story why. Next week: why the star trek community pushed a T1D kickstarter campaign over the top. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.  

Civica, Inc. (Civica, Civica Rx) announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market.  Dan Liljenquist, Board Chair of Civica Rx and Intermountain Healthcare Chief Strategy Officer​ calls in to explain what this is and when we will see it become available  See omnystudio.com/listener for privacy information.

The pharmaceutical industry, like many others, has room for improvement when it comes to diversity. Most recent studies show that approximately 1/3 of the top 50 pharma companies have no women on their board and only 8% of board seats are held by ethnically diverse directors, compared with 14% of the Fortune 500 overall. But there are signs that the industry is heading in the right direction by focusing more on diversity. Civica is an example, with women making up about half of the company's leadership team, the board of directors and leading critical parts of their business. On this episode of Dimensions of Diversity, host Lloyd Freeman talks to Jennifer Spalding, General Counsel and Chief Compliance Officer at Civica. The two discuss the need for improvement in diversity within the Pharma space and what Spalding and Civica are doing at her company to make a leading difference. To learn more about Civica, click here: https://civicarx.org/. To learn more about Lloyd Freeman, click here: https://www.bipc.com/lloyd-freeman. To learn more about Buchanan Ingersoll & Rooney, visit www.BIPC.com.